VX18-445-106


Study NameStudy TitleStudy TypeSponsorSponsor Type
VX18-445-106A Phase 3 Study Evaluating the Pharmacokinetics, Safety, and Tolerability of VX-445/TEZ/IVA Triple Combination Therapy in Cystic Fibrosis Subjects 6 Through 11 Years of Age.Clinical TrialVertexIndustry Sponsored